Brookline, MA, United States of America

Ronald K Blackman

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ronald K Blackman

Introduction

Ronald K Blackman is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of cancer therapy, holding 2 patents that focus on innovative pharmaceutical combinations aimed at treating proliferative disorders.

Latest Patents

One of his latest patents involves a cancer therapy using a combination of Hsp90 inhibitory compounds and an EGFR inhibitor. This patent describes a pharmaceutical combination comprising an EGFR inhibitor and an Hsp90 inhibitor, with specific structural formulae defined within the documentation. The methods provided in this patent aim to treat a proliferative disorder in subjects who are in need of such therapies. Another significant patent focuses on improved cancer treatments utilizing bis[thiohydrazide amide] compounds, such as elesclomol. This patent emphasizes the identification of patient populations that would benefit from these advanced treatments.

Career Highlights

Throughout his career, Ronald K Blackman has worked with Synta Pharmaceuticals Corporation, where he contributed to the development of innovative cancer therapies. His work has been instrumental in advancing the understanding and treatment of cancer.

Collaborations

Ronald has collaborated with notable professionals in the field, including Kevin Paul Foley and David Proia. These collaborations have further enriched his contributions to cancer research and therapy.

Conclusion

In summary, Ronald K Blackman is a distinguished inventor whose work in cancer therapy has led to significant advancements in the field. His innovative patents and collaborations highlight his commitment to improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…